ArticleArchives of Razi Institute2025
Assessing the Diagnostic Efficacy of a Developed Technique Utilizing Gold Nanoparticles in Diagnosis of Cystic Echinococcosis via the ELISA Method.
Article in Archives of Razi Institute, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cystic echinococcosis (CE) is a significant zoonotic disease, transmitted primarily from canines to intermediate hosts such as humans, sheep, and cattle. This disease is caused by the larval stage of the Echinococcus granulosus tapeworm. CE can lead to severe health complications, including liver and lung cysts, which can cause organ dysfunction and even death if left untreated. The present study utilized serum specimens from 25 newborn babies as the negative control group, while an additional 25 serum samples were collected from surgically confirmed cases of CE to serve as the positive control group.The Iranian native antigen B was used to design the specific detection of hydatidosis in humans using an AuNP-ELISA method.The AgB isolated from sheep CE fluid was used for the design using the AgB-ELISA method. The study was meticulously executed in three stages.Initially, the commercial ELISA kit was employed. The second method entailed the utilization of native AgB to devise the ELISA method. Ultimately, gold nanoparticles (AuNPs) with anti-human conjugate combination and AgB-ELISA method were employed. The results demonstrate that the sensitivity and specificity for the diagnosis of hydatidosis were 92% and 100%, respectively, using the commercial ELISA kit; 96% and 100% with the AgB-ELISA method; and 100% with the Gold Nanoparticle-ELISA method.The utilisation of Ag B in ELISA design for hydatidosis diagnosis has recently garnered significant attention from researchers in the field. The findings suggest that incorporating AgB in ELISA design is highly advantageous; however, sensitivity can be significantly enhanced by utilising gold nanoparticles with anti-human conjugate, particularly in cases with lower titers that require high accuracy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.